Regeneron Pharmaceuticals | REGN - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
AbbVie USD 6.57B 2.82B 2026-06
Agenus USD 35M 32M 2026-03
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 4.89B 2.67B 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 3.98B 33.45M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Kyowa Hakko Kirin JPY 218.77B 15.83B 2025-12
Merck USD 5.33B 9.24B 2026-03
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Pfizer USD 976M 727M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 5.54B 2.11B 2026-03
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
United Therapeutics USD 1.28B 277.4M 2026-03
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06